Skip to search formSkip to main contentSkip to account menu

Ticlopidine Hydrochloride

Known as: ticlopidine hcl, Ticlopidine Hydrochloride [Chemical/Ingredient], 5-(o-Chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridinium Chloride 
The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits… 
National Institutes of Health

Related topics

Related topics

13 relations
Blood Coagulation DisordersDrug AllergyHemorrhageIntracranial Embolism and Thrombosis

Narrower (3)

PanaldineTiclidTiclodone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Pharmacokinetic and pharmacological interactions between ticlopidine hydrochloride and Kangen‐Karyu – Chinese traditional herbal medicine
Kangen‐Karyu (KGK), containing peony root, cnidium rhizome, safflower, cyperus rhizome, saussurea root and Salvia miltiorrhiza… 
1997
1997
A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study.
Two treatments, based on either ticlopidine or indobufen at their optimal individual daily dose (median dose: 250 and 200 mg/day… 
Review
1996
Review
1996
Acute phenytoin toxicity followed by seizure breakthrough from a ticlopidine-phenytoin interaction.
OBJECTIVE To review a case of a drug-drug interaction between phenytoin sodium and ticlopidine hydrochloride that resulted in… 
1996
1996
Phenytoin toxicity associated with ticlopidine administration.
A case of phenytoin sodium toxicity that appeared to be related to the administration of ticlopidine hydrochloride was recently… 
1995
1995
Effect of KBT‐3022, a New Diphenylthiazole Derivative, on Platelet Functions
The effects of KBT‐3022 and its metabolite desethyl KBT‐3022 on platelet aggregation were determined in rat, guinea‐pig, rabbit… 
1994
1994
Ticlopidine hydrochloride use and threatened stroke.
Ticlopidine hydrochloride is an antiplatelet agent of proven antithrombotic efficacy that in December 1991 became available for… 
1994
1994
Ticlopidine hydrochloride: its current use in cerebrovascular disease.
It is estimated that half a million Americans will suffer strokes this year (National Stroke Association, 1989). The physical… 
Review
1992
Review
1992
Ticlopidine hydrochloride.
Ticlopidine, a new prototype antiplatelet agent, offers a significant alternative in the primary and secondary prevention of… 
1992
1992
Comparison of the Inhibitory Effects of the TXA2 Receptor Antagonist, Vapiprost, and Other Antiplatelet Drugs on Arterial Thrombosis in Rats: Possible Role of TXA2
Summary The antithrombotic effect of the thromboxane A2 receptor antagonist, vapiprost, was compared with those of other… 
1981
1981
The Effects Of Ticlopidine Hydrochloride On Bleeding Time And Platelet Function In Man
Ticlopidine hydrochloride (T) was given to healthy male and female subjects in doses ranging from 125-500 mg/day for up to 8 days… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)